UnknownNot Applicable

Radial Access for Abdominopelvic Vascular Intervention

China1,143 participantsStarted 2023-08-07

Plain-language summary

To evaluate the safety and efficacy of R.A.V.I.(radial access for abdominopelvic vascular intervention), and evaluate the feasibility and safety of repeated radial artery intervention

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥18 years old, gender is not limited;
✓. Patients who need abdominopelvic transarterial interventions
✓. Preoperative ultrasound assessment of radial artery diameter ≥2mm;
✓. Those with good radial pulse and normal Barbeau test (non-D wave);
✓. There was no infection, redness swelling or ulceration near the puncture site;
✓. Patients and(or) family members agreed to participate in the clinical study and signed informed consent

Exclusion criteria

✕. Has a history of severe allergy or intolerance to contrast media or chemotherapy drugs;
✕. Absence or occlusion of the radial artery pulse;
✕. Need large sheath (≥6Fr);
✕. Previous history of stroke;
✕. Patients with chronic kidney disease who need to establish dialysis access or preserve upper limb blood vessels in the future;
✕. Previous history of interventional procedure through radial artery approach (re-intervention of enrolled patients is not included);
✕. The investigator believes that the aortic calcification is severe. and the risk of plaque detachment is existed;
✕. Patients and(or) family members do not agree to join the clinical trials and sign the informed consent ;

What they're measuring

Technical success rate: radial artery puncture success rate and procedure success rate

Timeframe: up to 1 day after surgery

Puncture success rate and procedure success rate of repeated radial artery intervention

Timeframe: up to 1 day after surgery

Complications related to radial approach

Timeframe: up to 1 month after surgery

Trial details

NCT IDNCT05956860

SponsorZhongda Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-30

Contact for this trial

Hai-Dong Zhu, MD

+862583262224 zhuhaidong9509@163.com

View on ClinicalTrials.gov More Vascular Access Device Complications trials

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥18 years old, gender is not limited;
✓. Patients who need abdominopelvic transarterial interventions
✓. Preoperative ultrasound assessment of radial artery diameter ≥2mm;
✓. Those with good radial pulse and normal Barbeau test (non-D wave);
✓. There was no infection, redness swelling or ulceration near the puncture site;
✓. Patients and(or) family members agreed to participate in the clinical study and signed informed consent

Exclusion criteria

✕. Has a history of severe allergy or intolerance to contrast media or chemotherapy drugs;
✕. Absence or occlusion of the radial artery pulse;
✕. Need large sheath (≥6Fr);
✕. Previous history of stroke;
✕. Patients with chronic kidney disease who need to establish dialysis access or preserve upper limb blood vessels in the future;
✕. Previous history of interventional procedure through radial artery approach (re-intervention of enrolled patients is not included);
✕. The investigator believes that the aortic calcification is severe. and the risk of plaque detachment is existed;
✕. Patients and(or) family members do not agree to join the clinical trials and sign the informed consent ;

What they're measuring

Technical success rate: radial artery puncture success rate and procedure success rate

Timeframe: up to 1 day after surgery

Puncture success rate and procedure success rate of repeated radial artery intervention

Timeframe: up to 1 day after surgery

Complications related to radial approach

Timeframe: up to 1 month after surgery